U.S. markets closed
  • S&P 500

    4,577.11
    -85.74 (-1.84%)
     
  • Dow 30

    35,368.47
    -543.34 (-1.51%)
     
  • Nasdaq

    14,506.90
    -386.86 (-2.60%)
     
  • Russell 2000

    2,096.23
    -66.23 (-3.06%)
     
  • Crude Oil

    86.56
    +2.74 (+3.27%)
     
  • Gold

    1,813.40
    -3.10 (-0.17%)
     
  • Silver

    23.51
    +0.59 (+2.58%)
     
  • EUR/USD

    1.1329
    -0.0081 (-0.71%)
     
  • 10-Yr Bond

    1.8650
    +0.0930 (+5.25%)
     
  • GBP/USD

    1.3598
    -0.0049 (-0.36%)
     
  • USD/JPY

    114.5870
    +0.0070 (+0.01%)
     
  • BTC-USD

    42,383.26
    +536.01 (+1.28%)
     
  • CMC Crypto 200

    1,009.15
    -0.24 (-0.02%)
     
  • FTSE 100

    7,563.55
    -47.68 (-0.63%)
     
  • Nikkei 225

    28,257.25
    -76.27 (-0.27%)
     

Pear Therapeutics Stock Rises on First Day of Trading

·1 min read

Pear Therapeutics shares were rising by 5.4% in its first day of trading on Nasdaq. Pear, a developer of software-based medicines called prescription digital therapeutics, on Friday completed a merger with special purpose acquisition company Thimble Point Acquisition, whose stockholders on Nov. 30 voted to approve the business combination. Pear's shareholders had earlier approved the merger.